Add to ORKGTable 7. Interim recommendations for JYNNEOS vaccine administration errors and deviationsWhat You Need to Know -- Purpose and Scope
The Centers for Disease Control and Prevention (CDC) has updated its Guidance for Tecovirimat (TPOXX...
The Centers for Disease Control and Prevention (CDC) and state and local health departments continue...
The virus causing monkeypox, a rare zoonotic viral disease, belongs to the Poxviridae family and the...
Updated August 15, 2022Formerly called: Interim clinical considerations for use of JYNNEOS and ACAM2...
Table 6. Summary of Vaccination Administration Considerations for Specific Populations by Age and Me...
ACAM2000 is licensed by the U.S. Food and Drug Administration for immunization against smallpox dise...
This document provides interim guidance for healthcare professionals and public health officials reg...
supersedes: cdc:120086CDC recommends that vaccination with JYNNEOS can be considered for people dete...
Updated July 28, 2022Vaccine Strategies to Prevent Monkeypox -- Vaccine Information -- Planning Cons...
Last Updated 09/27/22Note: The 2022 U.S. monkeypox outbreak is rapidly evolving. This document addre...
Updated September 15, 2022CDC is closely tracking cases of monkeypox recently detected in the United...
Human monkeypox is an emerging viral zoonotic disease, that has caused highly distinctive, challengi...
Many individuals infected with monkeypox virus have a mild, self-limiting disease course in the abse...
Vaccination with JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic) to prevent monk...
Updated June 2, 2022When properly administered before an exposure, vaccines are effective at protect...
The Centers for Disease Control and Prevention (CDC) has updated its Guidance for Tecovirimat (TPOXX...
The Centers for Disease Control and Prevention (CDC) and state and local health departments continue...
The virus causing monkeypox, a rare zoonotic viral disease, belongs to the Poxviridae family and the...
Updated August 15, 2022Formerly called: Interim clinical considerations for use of JYNNEOS and ACAM2...
Table 6. Summary of Vaccination Administration Considerations for Specific Populations by Age and Me...
ACAM2000 is licensed by the U.S. Food and Drug Administration for immunization against smallpox dise...
This document provides interim guidance for healthcare professionals and public health officials reg...
supersedes: cdc:120086CDC recommends that vaccination with JYNNEOS can be considered for people dete...
Updated July 28, 2022Vaccine Strategies to Prevent Monkeypox -- Vaccine Information -- Planning Cons...
Last Updated 09/27/22Note: The 2022 U.S. monkeypox outbreak is rapidly evolving. This document addre...
Updated September 15, 2022CDC is closely tracking cases of monkeypox recently detected in the United...
Human monkeypox is an emerging viral zoonotic disease, that has caused highly distinctive, challengi...
Many individuals infected with monkeypox virus have a mild, self-limiting disease course in the abse...
Vaccination with JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic) to prevent monk...
Updated June 2, 2022When properly administered before an exposure, vaccines are effective at protect...
The Centers for Disease Control and Prevention (CDC) has updated its Guidance for Tecovirimat (TPOXX...
The Centers for Disease Control and Prevention (CDC) and state and local health departments continue...
The virus causing monkeypox, a rare zoonotic viral disease, belongs to the Poxviridae family and the...